Understanding Financial Toxicity in Cancer Treatment

This chapter features a listener's harrowing experience with advanced colon cancer and the high costs of unapproved medication. It delves into the systemic flaws in drug approval and pricing, emphasizing the financial burdens faced by patients and the pressing issues of healthcare equity.